Drug-Dependent Requirement of Hippocampal Neurogenesis in a Model of Depression and of Antidepressant Reversal
Biological PsychiatryPublished 12 April 2008
Alexandre Surget, Michael Saxe, Samuel Leman, Yadira Ibargüen-Vargas, Sylvie Chalon, Guy Griebel
Citations532
SJR quartileQ1
SJR score4.68
SNIP2.24
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
It is suggested that hippocampal neurogenesis might be used by the monoaminergic ADs to counteract the effects of stress, whereas similar effects could be achieved by directly targeting the HPA axis and related neuropeptides.
Abstract
Hippocampal neurogenesis might thus be used by the monoaminergic ADs to counteract the effects of stress, whereas similar effects could be achieved by directly targeting the HPA axis and related neuropeptides.
Keywords
PsychologyNeuroscience
ScienceInfluence of Life Stress on Depression: Moderation by a Polymorphism in the 5-HTT Gene
8,130 Citations2003Avshalom Caspi, Karen Sugden +9 more
Evidence of a gene-by-environment interaction is provided, in which an individual's response to environmental insults is moderated by his or her genetic makeup.
ScienceRequirement of Hippocampal Neurogenesis for the Behavioral Effects of Antidepressants
4,281 Citations2003Luca Santarelli, Michael Saxe +10 more
It is shown that disrupting antidepressant-induced neurogenesis blocks behavioral responses to antidepressants, suggesting that the behavioral effects of chronic antidepressants may be mediated by the stimulation of neuroGenesis in the hippocampus.
Journal of NeuroscienceChronic Antidepressant Treatment Increases Neurogenesis in Adult Rat Hippocampus
3,100 Citations2000Jessica E. Malberg, Amelia J. Eisch +2 more
Investigation of the effect of antidepressants on hippocampal neurogenesis in the adult rat using the thymidine analog bromodeoxyuridine (BrdU) as a marker for dividing cells demonstrates that chronic antidepressant treatment significantly increases the number of BrdU-labeled cells in the dentate gyrus and hilus of the hippocampus.
Archives of General PsychiatryGlucocorticoids and Hippocampal Atrophy in Neuropsychiatric Disorders
1,969 Citations2000Robert M. Sapolsky
This review examines the evidence for hippocampal atrophy in Cushing syndrome, which is characterized by a pathologic oversecretion of glucocorticoids; (2) episodes of repeated and severe major depression; (3) posttraumatic stress disorder and what cellular mechanisms underlie the overall decreases in hippocampal volume.
Proceedings of the National Academy of SciencesHippocampal atrophy in recurrent major depression.
1,923 Citations1996Yvette I. Sheline, P W Wang +3 more
The results suggest that depression is associated with hippocampal atrophy, perhaps due to a progressive process mediated by glucocorticoid neurotoxicity.
American Journal of PsychiatryHippocampal Volume Reduction in Major Depression
1,656 Citations2000J. Douglas Bremner, Meena Narayan +4 more
These findings are consistent with smaller left hippocampal volume in depression, and were significant after brain size, alcohol exposure, age, and education were controlled for.
Journal of NeuroscienceNeurogenesis in the Dentate Gyrus of the Adult Tree Shrew Is Regulated by Psychosocial Stress and NMDA Receptor Activation
1,482 Citations1997Elizabeth Gould, Bruce S. McEwen +3 more
Results indicate that adult neurogenesis occurs in the tree shrew dentate gyrus and is regulated by a stressful experience and NMDA receptor activation, and it is suggested that these characteristics may be common to most mammalian species.
Proceedings of the National Academy of SciencesProliferation of granule cell precursors in the dentate gyrus of adult monkeys is diminished by stress
1,386 Citations1998Elizabeth Gould, Patima Tanapat +3 more
The results suggest that neurons are produced in the dentate gyrus of adult monkeys and that the rate of precursor cell proliferation can be affected by a stressful experience.
Neuroscience & Biobehavioral ReviewsChronic mild stress-induced anhedonia: A realistic animal model of depression
1,142 Citations1992Paul Willner, Richard Muscat +1 more
The validity of chronic mild stress-induced anhedonia as an animal model of depression is reviewed, and the evidence that changes in hedonic responsiveness in this model are mediated by changes in the sensitivity of dopamine D2 receptors in the nucleus accumbens is reviewed.
Biological PsychiatryGlucocorticoid receptors in major depression: relevance to pathophysiology and treatment
1,140 Citations2001Carmine M. Pariante, Andrew H. Miller
The data support the hypothesis that the function of the GR is reduced in major depression in the absence of clear evidence of decreased GR expression and indicate that some antidepressants have direct effects on the GR, leading to enhanced GR function and increased GR expression.
Proceedings of the National Academy of SciencesStress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine
1,090 Citations2001Boldizsár Czéh, Thomas Michaelis +6 more
The effect of tianeptine, a modified tricyclic antidepressant, in the chronic psychosocial stress model of adult male tree shrews, a model with high validity for research on the pathophysiology of major depression, is investigated.
Proceedings of the National Academy of SciencesCourse of illness, hippocampal function, and hippocampal volume in major depression
978 Citations2003Glenda MacQueen, Stephanie Campbell +6 more
Comparing hippocampal function, as assessed by performance on hippocampal-dependent recollection memory tests, and hippocampal volumes, as measured in a 1.5-T magnetic resonance imager, in depressed subjects experiencing a postpubertal onset of depression revealed a significant logarithmic association between illness duration and hippocampusal volume.
Annals of the New York Academy of SciencesPlasticity of the Hippocampus: Adaptation to Chronic Stress and Allostatic Load
866 Citations2001Bruce S. McEwen
The working hypothesis is that structural plasticity in response to repeated stress starts out as an adaptive and protective response, but ends up as damage if the imbalance in the regulation of the key mediators is not resolved.
NeuropsychopharmacologyCell Proliferation in Adult Hippocampus is Decreased by Inescapable Stress: Reversal by Fluoxetine Treatment
810 Citations2003Jessica E. Malberg, Ronald S. Duman
It is reported that exposure to avoidance testing, regardless of pre-exposure to IS, decreases cell proliferation in the hippocampus, extending previous studies demonstrating downregulation of neurogenesis by exposure to acute stressors.
Journal of Psychiatric ResearchEffects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated
704 Citations2000Astrid Zobel, Thomas Nickel +5 more
The data suggested that CRH(1)-receptor blockade does not impair the corticotropin and cortisol secretory activity either at baseline or following an exogenous CRH challenge, and significant reductions in depression and anxiety scores are observed using both, patient and clinician ratings.
European Journal of NeuroscienceRepeated restraint stress suppresses neurogenesis and induces biphasic PSA‐NCAM expression in the adult rat dentate gyrus
653 Citations2003Kara Pham, Juan Nácher +2 more
Two studies subjected rats to acute or chronic restraint stress and assessed the proliferation, survival and differentiation of newly born cells in the dentate gyrus may help understand the basis for hippocampal shrinkage and raise questions about the ultimate reversibility of the effects of chronic stress.
Biological PsychiatryNeural plasticity to stress and antidepressant treatment
640 Citations1999Ronald S. Duman, Jessica E. Malberg +1 more
Adaptations at the cellular and molecular levels in response to stress and antidepressant treatment could represent a form of neural plasticity that contributes to the pathophysiology and treatment of depression.
Journal of Clinical InvestigationCannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects
525 Citations2005Jiang Wu
It is shown that both embryonic and adult rat hippocampal NS/PCs are immunoreactive for CB1 cannabinoid receptors, indicating that cannabinoids could act on CB1 receptors to regulate neurogenesis and supports the hypothesis that chronic HU210 treatment produces anxiolytic- and antidepressant-like effects likely via promotion of hippocampal Neurogenesis.
Neurochemical ResearchStress and Plasticity in the Limbic System
475 Citations2003Robert M. Sapolsky
The ability of severe and/or prolonged stress to impair hippocampal-dependent explicit learning and the plasticity that underlies it is reviewed, and the ability of mild and transient stress to facilitate such plasticity is examined.
Journal of NeuroscienceEvidence for hippocampal regulation of neuroendocrine neurons of the hypothalamo-pituitary-adrenocortical axis
463 Citations1989JP Herman, MK Schafer +5 more
The results suggest that the hippocampus exercises a tonic inhibitory role on ACTH secretagogue production in neuroendocrine neurons promoting ACTH release.
Proceedings of the National Academy of SciencesAnxiolytic- and antidepressant-like effects of the non-peptide vasopressin V <sub>1b</sub> receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders
462 Citations2002Guy Griebel, Jacques Simiand +6 more
Findings point to a role for vasopressin in the modulation of emotional processes via the V1b receptor, and suggest that its blockade may represent a novel avenue for the treatment of affective disorders.
Nature NeuroscienceHippocampal neurogenesis is not required for behavioral effects of environmental enrichment
450 Citations2006Dar Meshi, Michael R. Drew +7 more
It is reported that environmental enrichment alters behavior in mice regardless of their hippocampal neurogenic capability, providing evidence that the newborn cells do not mediate these effects of enrichment.
Neuroscience & Biobehavioral ReviewsRecent advances in animal models of chronic antidepressant effects: The novelty-induced hypophagia test
420 Citations2005Stephanie C. Dulawa, René Hen
The NIH paradigm provides a promising new model for investigations into the neurobiology underlying the antidepressant response, and a newly revised hyponeophagia paradigm is presented, called the novelty-induced hypophagía (NIH) test, which attempts to maximize the predictive validity and practicality of the test.
The Journal of Comparative NeurologyExposure to fox odor inhibits cell proliferation in the hippocampus of adult rats via an adrenal hormone‐dependent mechanism
369 Citations2001Patima Tanapat, Nicholas B. Hastings +3 more
It is suggested that stressful experiences rapidly diminish cell proliferation by increasing adrenal hormone levels, resulting in a transient decrease in the number of adult‐generated immature granule neurons.
NeuroscienceChronic stress attenuates glucocorticoid negative feedback: involvement of the prefrontal cortex and hippocampus
351 Citations2003Kazushige Mizoguchi, Atsushi Ishige +2 more
The results suggest that the abnormal changes in GRs in the higher centers of the hypothalamo-pituitary-adrenal axis are involved in the chronic stress-induced attenuation of the feedback.
The Journal of Clinical Endocrinology & Metabolism24-Hour Profiles of Adrenocorticotropin, Cortisol, and Growth Hormone in Major Depressive Illness: Effect of Antidepressant Treatment*
317 Citations1987Paul Linkowski, Julien Mendlewicz +6 more
It is demonstrated that a disorder of circadian rhythmicity characterizes acute episodes of major depressive illness and that this chronobiological abnormality as well as the hypersecretion of ACTH, cortisol, and GH are state rather than trait dependent.
Molecular PsychiatryBlockade of CRF1 or V1b receptors reverses stress-induced suppression of neurogenesis in a mouse model of depression
309 Citations2003Richard Alonso, Guy Griebel +4 more
Results point to an important role of CRF and AVP in the regulation of dentate neurogenesis, and suggest that CRF1 and V1b receptor antagonists may affect plasticity changes in the hippocampal formation, as do clinically effective antidepressants.
NeuropsychopharmacologyBehavioral Effects of Chronic Fluoxetine in BALB/cJ Mice Do Not Require Adult Hippocampal Neurogenesis or the Serotonin 1A Receptor
303 Citations2007Kerri A Holick, Daniel Lee +2 more
B/cJ mice show a robust response to chronic SSRI treatment in the FST, which is not mediated by an increase in new neurons in the hippocampus, and does not require the 5-HT1A receptor, suggesting that SSRIs can produce antidepressant-like effects via distinct mechanisms in different mouse strains.
Journal of Pharmacology and Experimental Therapeutics4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1 S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine Hydrochloride (SSR125543A), a Potent and Selective Corticotrophin-Releasing Factor1 Receptor Antagonist. II. Characterization in Rodent Models of Stress-Related Disorders
236 Citations2002Guy Griebel, Jacques Simiand +8 more
Results indicate that SSR125543A shows good activity in acute and chronic tests of unavoidable stress exposure, suggesting that it may have a potential in the treatment of depression and some forms of anxiety disorders.
Biological PsychiatryReduced cell proliferation in the dentate gyrusis not correlated with the development of learned helplessness
224 Citations2003Barbara Vollmayr, C. Simonis +3 more
These results are in line with reports that the rate of dentate gyrus cell proliferation is acutely down-regulated by stress, but the development of helpless behavior does not correlate with this process.
The Journal of Clinical PsychiatryHippocampal and Amygdala Changes in Patients With Major Depressive Disorder and Healthy Controls During a 1-Year Follow-Up
221 Citations2004Thomas Frodl, Eva Meisenzahl +9 more
The results do not support the hypothesis that hippocampal volumes diminish during the 1-year follow-up period, however, smaller hippocampusal volumes may be related to a poor clinical outcome after 1 year.
Journal of Pharmacology and Experimental TherapeuticsCharacterization of (2 S,4 R)-1-[5-Chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1 H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a Selective and Orally Active Vasopressin V1b Receptor Antagonist
210 Citations2002Claudine Serradeil‐Le Gal, Jean Wagnon +13 more
SSR149415 is a potent, selective, and orally active V1b receptor antagonist and deserves to be clinically investigated in the field of stress and anxiety.
Current Opinion in PsychiatryAn update on regional brain volume differences associated with mood disorders
196 Citations2005Stephanie Campbell, Glenda MacQueen
Patients’ age, sex, age at onset of disease, course of illness and treatment status may affect the detection of regional brain volume changes in people with mood disorders, including changes in amygdala volumes.
European Journal of PharmacologyEffects of desipramine and tramadol in a chronic mild stress model in mice are altered by yohimbine but not by pindolol
174 Citations2005İpek Yalçın, Fazilet Aksu +1 more
The suggestion that antidepressant-like effect of tramadol and desipramine in mice in the unpredictable chronic mild stress model is mediated by the noradrenergic system rather than the serotonergic system is supported.
Psychiatry Research NeuroimagingHPA axis dysfunction in unmedicated major depressive disorder and its normalization by pharmacotherapy correlates with alteration of neural activity in prefrontal cortex and limbic/paralimbic regions
172 Citations2007Masako Aihara, Itsuro Ida +9 more
Results indicate that depressed patients remitted with antidepressant treatment were accompanied by resolution of HPA dysregulation and alteration of regional glucose metabolism in the prefrontal cortical, limbic and paralimbic regions.
Molecular PsychiatrySubstance P receptor antagonist and clomipramine prevent stress-induced alterations in cerebral metabolites, cytogenesis in the dentate gyrus and hippocampal volume
157 Citations2002Marieke G. C. van der Hart, Boldizsár Czéh +6 more
The results suggest that—despite a different pharmacological profile—the NK1R antagonist L-760,735, a member of a novel class of antidepressant drugs, has comparable neurobiological efficacy to tricyclic antidepressants such as clomipramine.
NeuroRxNeural circuitry and neuroplasticity in mood disorders: Insights for novel therapeutic targets
151 Citations2006Paul J. Carlson, Jaskaran Singh +3 more
Modulation of dysregulated activity in these affective circuits via pharmacological agents that enhance neuronal resilience and plasticity, and possibly via emerging nonpharmacologic, circuitry-based modalities offers promising targets for novel experimental therapeutics in the treatment of mood disorders.
NeuroscienceFunctional implications of decreases in neurogenesis following chronic mild stress in mice
144 Citations2007Yann S. Mineur, Catherine Belzung +1 more
Results demonstrated a dramatic reduction of surviving new brain cells in both the hippocampus and the subventricular zone of UCMS-treated animals, and there does not appear to be a direct causative relationship between the deficits in neurogenesis and behavior.
Behavioural Brain ResearchCorrelations between behaviours in the elevated plus-maze and sensitivity to unpredictable subchronic mild stress: evidence from inbred strains of mice
139 Citations2004C. Ducottet, Catherine Belzung
The results suggest that anxiety may be a factor contributing, among others, to the susceptibility to depressive-like behaviours and the free exploratory paradigm is slightly associated with behaviours in the two tests of depression.
NeuropsychopharmacologyHigh-Affinity CRF1 Receptor Antagonist NBI-34041: Preclinical and Clinical Data Suggest Safety and Efficacy in Attenuating Elevated Stress Response
138 Citations2007Marcus Ising, U. Zimmermann +6 more
It is suggested that NBI-34041 is safe and does not impair basal regulation of the HPA system but improves resistance against psychosocial stress and demonstrates that inhibition of the CRF system is a promising target for drug development against depression and anxiety disorders.
Journal of Psychiatric ResearchTreatment of depression with the CRH-1-receptor antagonist R121919: endocrine changes and side effects
134 Citations2003Heike Künzel, Astrid Zobel +6 more
There were no adverse effects or impairment of the hypothalamus-pituitary-gonadal system, the hypothalamic-pituitsary-thyroid axis, the renin-angiotensin system, prolactin or vasopressin secretion, and the effects of R121919 on clinical laboratory parameters including liver enzymes, EEG and ECG were observed.
PsychopharmacologyEffets des anxiolytiques sur la prise de nourriture de rats et de souris plac�s en situation nouvelle ou famili�re
118 Citations1975P. Soubri�, Sachin Kulkarni +2 more
The results and the observation of anti-anxiety drugs-induced hyperphagia in satiated animals suggest that minor tranquilizers reduce the latency before eating of rats and mice tested in a new situation.
Biochemical and Biophysical Research CommunicationsIncreased cell proliferation in the adult mouse hippocampus following chronic administration of group II metabotropic glutamate receptor antagonist, MGS0039
113 Citations2004Takao Yoshimizu, Shigeyuki Chaki
This is the first in vivo study to demonstrate an increase in cell proliferation following a blockade of group II mGluRs, and raises the possibility that MGS0039 may exert antidepressant-like effects by modulating cell proliferation in the hippocampus.
European PsychiatryStructural plasticity and tianeptine: cellular and molecular targets
105 Citations2002Bruce S. McEwen, Ana Marı́a Magariños +1 more
Findings on neurochemical targets of adrenal steroid actions that may explain their role in the remodeling process are summarized to better understand the molecular and cellular targets of action of tianeptine in relation to its role in influencing structural plasticity of the hippocampus.
PharmacopsychiatryThe Hypothalamic-Pituitary-Adrenal System in Depression
102 Citations1998Isabella Heuser
It is concluded that dampening of HPA system hyperactivity in depression by means of antidepressants is a conditio sine qua non for successful improvement of psychopathology.
CNS SpectrumsPharmacologic Differences Among the SSRIs: Focus on Monoamine Transporters and the HPA Axis
89 Citations2004Charles B. Nemeroff, Michael J. Owens
Each SSRI apparently has its own unique pharmacologic properties that likely underlie their observed differences in clinical use, and certain SSRIs have been shown to reduce the activity of CRF neurons and may contribute to their therapeutic action.
Pharmacology Biochemistry and BehaviorComparison of the V1b antagonist, SSR149415, and the CRF1 antagonist, CP-154,526, in rodent models of anxiety and depression
78 Citations2007Robert A. Hodgson, Guy A. Higgins +7 more
This work demonstrates the different profiles of V1b and CRF1 receptor antagonists and supports both approaches in the treatment of affective disorders.
Journal of Pharmacology and Experimental Therapeutics4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1 S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1,3-thiazol-2-amine Hydrochloride (SSR125543A): A Potent and Selective Corticotrophin-Releasing Factor1 Receptor Antagonist. I. Biochemical and Pharmacological Characterization
75 Citations2002Danielle Gully, Michel Geslin +19 more
SSR125543A is a potent, selective, and orally active CRF(1) receptor antagonist, and its brain penetration was demonstrated in rats by using an ex vivo ovine CRF binding assay.
Molecular PsychiatryChronic fluoxetine treatment alters behavior, but not adult hippocampal neurogenesis, in BALB/cJ mice
74 Citations2008Guo‐Jen Huang, David M. Bannerman +1 more
It is found that chronic fluoxetine treatment alters behavior, but not adult hippocampal neurogenesis, in BALB/cJ mice, while sham treatment with a similar drug results in the opposite direction.
PubMedElucidating the antidepressant actions of substance P (NK1 receptor) antagonists.
54 Citations2002N.M.J. Rupniak
Studies in animals indicate that the psychotherapeutic effects of SPAs may be mediated at least partly through stimulation of hippocampal neurogenesis, by direct blockade of NK1 receptors in the amygdala and its associated output projections, and also via interactions with monoamines.
PsychopharmacologyThe CRF 1 receptor antagonist DMP696 produces anxiolytic effects and inhibits the stress-induced hypothalamic-pituitary-adrenal axis activation without sedation or ataxia in rats
42 Citations2002John Mcelroy, Kathryn Ward +5 more
The data suggest that the CRF1 antagonist DMP696 might retain the therapeutic benefits of classical benzodiazepines but have fewer motoric side effects.
NeuropsychopharmacologyAntidepressant-Like Effects of the Corticotropin-Releasing Factor 1 Receptor Antagonist, SSR125543, and the Vasopressin 1b Receptor Antagonist, SSR149415, in a DRL-72 s Schedule in the Rat
40 Citations2006Caroline Louis, Caroline Cohen +2 more
Results show that SSR149415 and SSR125543 displayed antidepressant-like activity in a DRL-72 s schedule in rat, confirming their therapeutic potential for the treatment of pathological states induced by chronic frustration such as depression.
PsychopharmacologyThe anxiolytic CRF1 antagonist DMP696 fails to function as a discriminative stimulus and does not substitute for chlordiazepoxide in rats
12 Citations2003Snježana Lelas, Kim Zeller +2 more
Lack of substitution of DMP696 for the chlordiazepoxide DS in rats and its inability to acquire DS properties suggest that the DS effects of D MP696 differ from those of benzodiazepines.